Literature DB >> 11264316

Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons.

A A Coutts1, S Anavi-Goffer, R A Ross, D J MacEwan, K Mackie, R G Pertwee, A J Irving.   

Abstract

Agonist-induced internalization of G-protein-coupled receptors is an important mechanism for regulating receptor abundance and availability at the plasma membrane. In this study we have used immunolabeling techniques and confocal microscopy to investigate agonist-induced internalization and trafficking of CB(1) receptors in rat cultured hippocampal neurons. The levels of cell surface CB(1) receptor immunoreactivity associated with presynaptic GABAergic terminals decreased markedly (by up to 84%) after exposure to the cannabinoid agonist (+)-WIN55212, in a concentration-dependent (0.1-1 microm) and stereoselective manner. Inhibition was maximal at 16 hr and abolished in the presence of SR141716A, a selective CB(1) receptor antagonist. Methanandamide (an analog of an endogenous cannabinoid, anandamide) also reduced cell surface labeling (by 43% at 1 microm). Differential labeling of cell surface and intracellular pools of receptor demonstrated that the reduction in cell surface immunoreactivity reflects agonist-induced internalization and suggests that the internalized CB(1) receptors are translocated toward the soma. The internalization process did not require activated G-protein alpha(i) or alpha(o) subunits. A different pattern of cell surface CB(1) receptor expression was observed using an undifferentiated F-11 cell line, which had pronounced somatic labeling. In these cells substantial CB(1) receptor internalization was also observed after exposure to (+)-WIN55212 (1 microm) for relatively short periods (30 min) of agonist exposure. In summary, this dynamic modulation of CB(1) receptor expression may play an important role in the development of cannabinoid tolerance in the CNS. Agonist-induced internalization at presynaptic terminals has important implications for the modulatory effects of G-protein-coupled receptors on neurotransmitter release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264316      PMCID: PMC6762401     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

Review 1.  The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells.

Authors:  A C Howlett; T M Champion-Dorow; L L McMahon; T M Westlake
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

2.  Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type.

Authors:  J A Koenig; J M Edwardson
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

3.  CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells.

Authors:  H H McIntosh; C Song; A C Howlett
Journal:  Brain Res Mol Brain Res       Date:  1998-01

4.  Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists.

Authors:  B Dumartin; I Caillé; F Gonon; B Bloch
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

5.  Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons.

Authors:  A J Irving; A A Coutts; J Harvey; M G Rae; K Mackie; G S Bewick; R G Pertwee
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Neuronal traits of clonal cell lines derived by fusion of dorsal root ganglia neurons with neuroblastoma cells.

Authors:  D Platika; M H Boulos; L Baizer; M C Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.

Authors:  A G Hohmann; M Herkenham
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

8.  Localization of cannabinoid receptor mRNA in rat brain.

Authors:  L A Matsuda; T I Bonner; S J Lolait
Journal:  J Comp Neurol       Date:  1993-01-22       Impact factor: 3.215

9.  Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception.

Authors:  R A Ross; A A Coutts; S M McFarlane; S Anavi-Goffer; A J Irving; R G Pertwee; D J MacEwan; R H Scott
Journal:  Neuropharmacology       Date:  2001       Impact factor: 5.250

10.  Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.

Authors:  A A Coutts; R G Pertwee
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

View more
  62 in total

1.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

Review 2.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

Review 3.  Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Authors:  Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Ligand-induced internalization of the orexin OX(1) and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

5.  The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

Authors:  Garron T Dodd; Giacomo Mancini; Beat Lutz; Simon M Luckman
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 6.  Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years.

Authors:  Alex Straiker; Ken Mackie
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

7.  Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.

Authors:  Tanya L Daigle; Christopher S Kearn; Ken Mackie
Journal:  Neuropharmacology       Date:  2007-06-26       Impact factor: 5.250

8.  Novel endogenous peptide agonists of cannabinoid receptors.

Authors:  Ivone Gomes; Julia S Grushko; Urszula Golebiewska; Sascha Hoogendoorn; Achla Gupta; Andrea S Heimann; Emer S Ferro; Suzanne Scarlata; Lloyd D Fricker; Lakshmi A Devi
Journal:  FASEB J       Date:  2009-04-20       Impact factor: 5.191

Review 9.  Activation of G-proteins in brain by endogenous and exogenous cannabinoids.

Authors:  Steven R Childers
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

Review 10.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.